Hierarchical graph representation learning with multi-granularity features for anti-cancer drug response prediction

|

|

Summary

This summary is machine-generated.

Predicting patient response to cancer drugs is vital. A new Hierarchical graph representation Learning with Multi-Granularity features (HLMG) model accurately forecasts anti-cancer drug responses by analyzing complex cell line and drug interactions.

Area Of Science

  • Computational biology
  • Genomics
  • Drug discovery

Background

  • Individual cancer patients exhibit varied responses to the same drug due to unique genomic profiles.
  • Accurate prediction of drug response is essential for personalized cancer treatment and improved patient outcomes.
  • Existing computational models often struggle with the complex multi-level interactions between cell lines and drugs.

Purpose Of The Study

  • To develop a novel algorithm, Hierarchical graph representation Learning with Multi-Granularity features (HLMG), for enhanced prediction of anti-cancer drug responses.
  • To integrate multi-granularity features of cell lines (gene expression, pathway substructures) and drugs (molecular fingerprints, substructures).
  • To leverage a heterogeneous graph and graph convolutional network for learning complex cell line-drug interactions.

Main Methods

  • Constructed a heterogeneous graph incorporating cell lines, drugs, known responses, and similarity associations.
  • Employed a graph convolutional network to learn representations by aggregating multi-level neighbor features.
  • Utilized a linear correlation coefficient decoder to predict the cell line-drug correlation matrix.

Main Results

  • The HLMG model demonstrated superior performance in predicting anti-cancer drug responses compared to existing state-of-the-art methods.
  • Validation was performed using the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE) databases.
  • The HLMG algorithm effectively captures complex biological interactions for more accurate predictions.

Conclusions

  • The HLMG algorithm offers a significant advancement in predicting anti-cancer drug efficacy.
  • This approach holds promise for guiding personalized cancer therapy and improving treatment strategies.
  • HLMG's ability to model multi-level interactions is key to its enhanced predictive accuracy.

Related Concept Videos

Protein Networks 02:26

3.9K

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Treatment Resistant Cancers 02:56

3.3K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Survival Analysis 01:21

328

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Dose-Response Relationship: Overview 01:03

3.0K

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...

Combination Therapies and Personalized Medicine 02:50

4.9K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cardiovascular Drugs: Classification based on Therapeutic Indications 01:18

2.1K

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...